日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Evaluation of Plasma Polyethylene Glycol (PEG) Levels in a Healthy Adult Population

健康成年人群血浆聚乙二醇（PEG）水平的评估

期刊:International Journal of Toxicology
影响因子:1
doi:10.1177/10915818251371966
Kubesch, Klaus; Lubich, Christian; Mascher, Daniel; Tangada, Srilatha; Turecek, Peter L
发表日期：2025
文献求助 收藏

Immunogenicity profile of rurioctocog alfa pegol in previously treated patients with severe congenital hemophilia A

rurioctocog alfa pegol 在既往接受过治疗的重型先天性血友病 A 患者中的免疫原性特征

期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2023011780
Horling, Frank M; Reipert, Birgit M; Allacher, Peter; Engl, Werner; Pan, Luying; Tangada, Srilatha
免疫/内分泌
发表日期：2024
文献求助 收藏

Targeting an elevated FVIII level using personalized rurioctocog alfa pegol prophylaxis in specific patient populations with hemophilia A: post hoc subanalysis of the randomized, phase 3 PROPEL study

在特定A型血友病患者群体中，采用个性化rurioctocog alfa pegol预防治疗以降低FVIII水平：随机3期PROPEL研究的事后亚组分析

期刊:Therapeutic Advances in Hematology
影响因子:3.1
doi:10.1177/20406207231178596
Escuriola-Ettingshausen, Carmen; Klamroth, Robert; Escobar, Miguel; Stasyshyn, Oleksandra; Tangada, Srilatha; Engl, Werner; Honauer, Ivan; Lee, Hye-Youn; Chowdary, Pratima; Windyga, Jerzy
发表日期：2023
文献求助 收藏

Rurioctocog alfa pegol PK-guided prophylaxis in hemophilia A: results from the phase 3 PROPEL study

在A型血友病中，基于药代动力学指导的Rurioctocog alfa pegol预防性治疗：PROPEL 3期研究结果

期刊:Blood
影响因子:23.1
doi:10.1182/blood.2020005673
Klamroth, Robert; Windyga, Jerzy; Radulescu, Vlad; Collins, Peter W; Stasyshyn, Oleksandra; Ibrahim, Hishamshah Mohd; Engl, Werner; Tangada, Srilatha D; Savage, William; Ewenstein, Bruce
发表日期：2021
文献求助 收藏

Results of a randomized phase III/IV trial comparing intermittent bolus versus continuous infusion of antihaemophilic factor (recombinant) in adults with severe or moderately severe haemophilia A undergoing major orthopaedic surgery

一项随机III/IV期试验的结果比较了在接受大型骨科手术的重度或中度重度A型血友病成人患者中，间歇性推注与持续输注抗血友病因子（重组）的疗效。

期刊:Haemophilia
影响因子:3
doi:10.1111/hae.14219
Pabinger, Ingrid; Mamonov, Vasily; Windyga, Jerzy; Engl, Werner; Doralt, Jennifer; Tangada, Srilatha; Spotts, Gerald; Ewenstein, Bruce
发表日期：2021
文献求助 收藏

Postauthorization safety surveillance study of antihaemophilic factor (recombinant) reconstituted in 2 mL sterile water for injection in children with haemophilia A

抗血友病因子（重组）溶于2 mL注射用无菌水中，用于治疗A型血友病患儿的上市后安全性监测研究

期刊:Haemophilia
影响因子:3
doi:10.1111/hae.13997
Motwani, Jayashree; Guillet, Benoit; Blatny, Jan; Schilling, Freimut H; Wibaut, Bénédicte; Goldstine, Jimena; Nagy, Andras; Doralt, Jennifer; Engl, Werner; Tangada, Srilatha; Spotts, Gerald
发表日期：2020
文献求助 收藏

Safety, Immunogenicity, and Hemostatic Efficacy of Nonacog Gamma in Patients With Severe or Moderately Severe Hemophilia B: A Continuation Study

Nonacog Gamma 在重度或中重度 B 型血友病患者中的安全性、免疫原性和止血疗效：一项后续研究

期刊:Clinical and Applied Thrombosis-Hemostasis
影响因子:2
doi:10.1177/1076029620950836
Windyga, Jerzy; Stasyshyn, Oleksandra; Lissitchkov, Toshko; Mamonov, Vasily; Serban, Margit; Rusen, Luminita; Ploder, Bettina; Tangada, Srilatha
免疫/内分泌
发表日期：2020
文献求助 收藏

Perioperative haemostasis with full-length, PEGylated, recombinant factor VIII with extended half-life (rurioctocog alfa pegol) in patients with haemophilia A: Final results of a multicentre, single-arm phase III trial

在A型血友病患者中，使用全长、聚乙二醇化、半衰期延长的重组因子VIII（rurioctocog alfa pegol）进行围手术期止血：一项多中心、单臂III期试验的最终结果

期刊:Haemophilia
影响因子:3
doi:10.1111/hae.13807
Gruppo, Ralph; López-Fernández, Maria-Fernanda; Wynn, Tung T; Engl, Werner; Sharkhawy, Marlies; Tangada, Srilatha
发表日期：2019
文献求助 收藏

Subgroup analysis of a phase 2/3 study of rurioctocog alfa pegol in patients with severe hemophilia A: efficacy and safety in previously treated Korean patients

一项针对重度血友病A患者的rurioctocog alfa pegol II/III期研究的亚组分析：既往接受过治疗的韩国患者的疗效和安全性

期刊:Blood Research
影响因子:2.8
doi:10.5045/br.2019.54.3.198
You, Chur Woo; Baek, Hee Jo; Park, Sang Kyu; Park, Young Shil; Shin, Ho-Jin; Engl, Werner; Tangada, Srilatha
发表日期：2019
文献求助 收藏

Blood, blood components, plasma, and plasma products

血液、血液成分、血浆和血浆制品

期刊:Clinical and Applied Thrombosis-Hemostasis
影响因子:2
doi:10.1177/1076029620946839
Windyga, Jerzy; Timofeeva, Margarita; Stasyshyn, Oleksandra; Mamonov, Vasily; Lamas Castellanos, José Luis; Lissitchkov, Toshko; Chojnowski, Krzysztof; Chapman, Miranda; Pavlova, Borislava G; Tangada, Srilatha; Choi, Seohyun (Claudia); Casias, Michael; Tompkins, Danielle; Gonzalez, Jimmy; Ray, Sidhartha D
发表日期：2019
文献求助 收藏